Allostery in homodimeric SARS-CoV-2 main protease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Allostery in homodimeric SARS-CoV-2 main protease ; volume:7 ; number:1 ; day:4 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
Communications biology ; 7, Heft 1 (4.11.2024), 1-16, 12.2024

Creator: Fornasier, Emanuele
Fabbian, Simone
Shehi, Haidi
Enderle, Janine
Gatto, Barbara
Volpin, Daniele
Biondi, Barbara
Bellanda, Massimo
Giachin, Gabriele
Sosic, Alice
Battistutta, Roberto

Contributor: SpringerLink (Online service)

DOI: 10.1038/s42003-024-07138-w

URN: urn:nbn:de:101:1-2501222111001.095402319850

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Fornasier, Emanuele
Fabbian, Simone
Shehi, Haidi
Enderle, Janine
Gatto, Barbara
Volpin, Daniele
Biondi, Barbara
Bellanda, Massimo
Giachin, Gabriele
Sosic, Alice
Battistutta, Roberto
SpringerLink (Online service)

Other Objects (12)

α-Ketoamide Inhibitors of SARS-CoV-2 Main Protease

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)

SARS‐CoV‐2 main protease mutation analysis via a kinematic method

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors

Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors

α-Ketoamide Inhibitors of SARS-CoV-2 Main Protease

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)

SARS‐CoV‐2 main protease mutation analysis via a kinematic method

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors

Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors

α-Ketoamide Inhibitors of SARS-CoV-2 Main Protease

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)

SARS‐CoV‐2 main protease mutation analysis via a kinematic method

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors

Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Allostery in homodimeric SARS-CoV-2 main protease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

α-Ketoamide Inhibitors of SARS-CoV-2 Main Protease

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)

SARS‐CoV‐2 main protease mutation analysis via a kinematic method

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors

Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors

α-Ketoamide Inhibitors of SARS-CoV-2 Main Protease

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)

SARS‐CoV‐2 main protease mutation analysis via a kinematic method

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors

Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors

α-Ketoamide Inhibitors of SARS-CoV-2 Main Protease

Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro)

SARS‐CoV‐2 main protease mutation analysis via a kinematic method

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease

Action of Dipeptidyl Peptidase‐4 Inhibitors on SARS‐CoV‐2 Main Protease

The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

SARS‐CoV‐2 Papain‐Like Protease: Structure, Function and Inhibition

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors

Cell type-specific anti-viral effects of novel SARS-CoV-2 main protease inhibitors

Related objects

Reset password